LIFECORE BIOMEDICAL, INC. Fair Value Inputs, Long-term Revenue Growth Rate (Deprecated 2018-01-31)
LIFECORE BIOMEDICAL, INC. (LFCR) reported Fair Value Inputs, Long-term Revenue Growth Rate (Deprecated 2018-01-31) of 6.00% for the 9-month period ending 2018-02-25, per its 10-Q filed 2018-04-05.
Discontinued › Income Statement › Other Income
us-gaap:FairValueInputsLongTermRevenueGrowthRate · last filed 2018-04-05
- LIFECORE BIOMEDICAL, INC. fair value inputs, long-term revenue growth rate (deprecated 2018-01-31) for the quarter ending 2017-08-27 was 4.00%, a 0.00% change year-over-year.
- LIFECORE BIOMEDICAL, INC. fair value inputs, long-term revenue growth rate (deprecated 2018-01-31) for the quarter ending 2016-08-28 was 4.00%, a 0.00% change year-over-year.
- LIFECORE BIOMEDICAL, INC. fair value inputs, long-term revenue growth rate (deprecated 2018-01-31) for the quarter ending 2015-08-30 was 4.00%, a 0.00% change year-over-year.
- LIFECORE BIOMEDICAL, INC. fair value inputs, long-term revenue growth rate (deprecated 2018-01-31) for the quarter ending 2014-08-31 was 4.00%.
- LIFECORE BIOMEDICAL, INC. fair value inputs, long-term revenue growth rate (deprecated 2018-01-31) for fiscal 2016 was 4.00%.
- LIFECORE BIOMEDICAL, INC. fair value inputs, long-term revenue growth rate (deprecated 2018-01-31) for fiscal 2014 was 4.00%.
| Period end | Fair Value Inputs, Long-term Revenue Growth Rate (Deprecated 2018-01-31) 3 month | Fair Value Inputs, Long-term Revenue Growth Rate (Deprecated 2018-01-31) 6 month | Fair Value Inputs, Long-term Revenue Growth Rate (Deprecated 2018-01-31) 9 month | Fair Value Inputs, Long-term Revenue Growth Rate (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2018-02-25 | 6.00% 10-Q · filed 2018-04-05 | |||
| 2017-11-26 | 4.00% 10-Q · filed 2018-01-05 | |||
| 2017-08-27 | 4.00% 10-Q · filed 2017-09-28 | |||
| 2017-05-28 | 4.00% 10-Q · filed 2018-04-05 | |||
| 2017-02-26 | 4.00% 10-Q · filed 2017-04-07 | |||
| 2016-11-27 | 4.00% 10-Q · filed 2017-01-05 | |||
| 2016-08-28 | 4.00% 10-Q · filed 2016-09-29 | |||
| 2016-05-29 | 4.00% 10-K/A · filed 2018-03-15 | |||
| 2016-02-28 | 4.00% 10-Q · filed 2016-03-30 | |||
| 2015-11-29 | 4.00% 10-Q · filed 2016-01-07 | |||
| 2015-08-30 | 4.00% 10-Q · filed 2015-10-01 | |||
| 2015-05-31 | 4.00% 10-Q · filed 2015-10-01 | |||
| 2015-03-01 | 4.00% 10-Q · filed 2015-04-02 | |||
| 2014-11-30 | 4.00% 10-Q · filed 2015-01-09 | |||
| 2014-08-31 | 4.00% 10-Q · filed 2014-10-08 | |||
| 2014-05-25 | 4.00% 10-K · filed 2015-07-31 | |||
| 2014-02-23 | 4.00% 10-Q · filed 2014-03-28 | |||
| 2013-11-24 | 3.00% 10-Q · filed 2014-01-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |